Applied Biological Research

  • Year: 2019
  • Volume: 21
  • Issue: 3

Interleukin 13 (IL-13) acts as a profibrotic cytokine for recruitment of myofibroblasts in oral submucous fibrosis

  • Author:
  • Mamatha G.S. Reddy1,, Sachin C. Sarode2, Rajiv S. Desai3
  • Total Page Count: 7
  • Published Online: May 1, 2019
  • Page Number: 221 to 227

1D.Y. Patil Vidyapeeth's, Dr. D.Y. Patil Dental College and Hospital, Pimpri, Pune-411 018, Maharashtra (India)

2D.Y. Patil Vidyapeeth's, Dr. D.Y. Patil Dental College and Hospital, Pimpri, Pune-411 018, Maharashtra (India)drsachinsarode@gmail.com

3Nair Dental Hospital and College, Mumbai, 400 008, Maharashtra (India)nansrd@hotmail.com

Abstract

Oral submucous fibrosis (OSF) is a chronic inflammatory condition due to areca nut (Areca catechu) chewing which induces fibrosis leading to the difficulty in mouth opening. Various profibrotic cytokines and chemokines have been found involved in fibrosis. The present study was aimed to find the role of interleukin 13 (IL-13) in recruiting the myofibroblasts and as a causative factor for fibrosis in OSF. Twenty-five sections of OSF tissue and ten sections of normal mucosa were stained with IL-13, TGF-α1 and β-SMA antibodies using immunohistochemical method. Immunostaining was done to assess staining intensity and percentage of positive cells. The results were analyzed by SPSS software. The expression of all three markers IL-13, TGF- β1 and α-SMA showed significant difference between control and OSF (p < 0.001), control and early OSF (p < 0.001) control and advanced OSF (p < 0.001). No statistical difference was found between early OSF and advanced OSF. Significant expression of IL-13 and its correlation with TGF-β and α-SMA suggests its role in pathogenesis of OSF.

Keywords

Interleukin 13, Myofibroblasts, Oral submucous fibrosis, Pathogenesis, Transforming growth factor-β